Cargando…
Oral Probiotic Control Skin Inflammation by Acting on Both Effector and Regulatory T Cells
Probiotics are believed to alleviate allergic and inflammatory skin disorders, but their impact on pathogenic effector T cells remains poorly documented. Here we show that oral treatment with the probiotic bacteria L. casei (DN-114 001) alone alleviates antigen-specific skin inflammation mediated by...
Autores principales: | Hacini-Rachinel, Feriel, Gheit, Hanane, Le Luduec, Jean-Benoit, Dif, Fariel, Nancey, Stéphane, Kaiserlian, Dominique |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654141/ https://www.ncbi.nlm.nih.gov/pubmed/19300508 http://dx.doi.org/10.1371/journal.pone.0004903 |
Ejemplares similares
-
Topical Ivermectin 10 mg/g and Oral Doxycycline 40 mg Modified-Release: Current Evidence on the Complementary Use of Anti-Inflammatory Rosacea Treatments
por: Steinhoff, Martin, et al.
Publicado: (2016) -
Beneficial effect of hydrolyzed egg in allergy
por: Nutten, Sophie, et al.
Publicado: (2011) -
Cytosolic phospholipase A2α mediates Pseudomonas aeruginosa LPS-induced airway constriction of CFTR -/- mice
por: Wu, Yong-Zheng, et al.
Publicado: (2010) -
EZH2 is crucial for both differentiation of regulatory T cells and T effector cell expansion
por: Yang, Xiang-Ping, et al.
Publicado: (2015) -
Regulatory CD4(+)Foxp3(+) T Cells Control the Severity of Anaphylaxis
por: Kanjarawi, Reem, et al.
Publicado: (2013)